1 January 2017 - The 1 January 2017 issue of the Schedule of Pharmaceutical Benefits sees a number of new listings.

The new listings are:

• Glycomacropeptide and essential amino acids with vitamins and minerals (PKU Bettermilk Lite) - new formulation
  
• Grazoprevir with elbasvir (Zepatier) - new combination product
  
• Mepolizumab (Nucala) - new medicine
  
• Riociguat (Adempas) - new medicine
  

Read summary of changes